<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Strata Critical Medical, Inc. — News on 6ix</title>
    <link>https://6ix.com/company/strata-critical-medical-inc</link>
    <description>Latest news and press releases for Strata Critical Medical, Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 20 Apr 2026 20:05:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/strata-critical-medical-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d7871551cc36e475343a2f.webp</url>
      <title>Strata Critical Medical, Inc.</title>
      <link>https://6ix.com/company/strata-critical-medical-inc</link>
    </image>
    <item>
      <title>Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-schedules-first-quarter-2026-earnings-conference-call</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-schedules-first-quarter-2026-earnings-conference-call</guid>
      <pubDate>Mon, 20 Apr 2026 20:05:00 GMT</pubDate>
      <description>NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and</description>
    </item>
    <item>
      <title>Strata Critical Medical Announces Fourth Quarter 2025 Results</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-announces-fourth-quarter-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-announces-fourth-quarter-2025-results</guid>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <description>Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata&apos;s organic growthFull year 2025 net loss from continuing operations was $20.1 millionFull year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance rangeRaising full year 2026 revenue guidance to between $260 and $275 million and Adjusted E</description>
    </item>
    <item>
      <title>Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-schedules-fourth-quarter-2025-earnings-conference-call</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-schedules-fourth-quarter-2025-earnings-conference-call</guid>
      <pubDate>Tue, 10 Feb 2026 05:00:00 GMT</pubDate>
      <description>NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth</description>
    </item>
    <item>
      <title>Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-announces-closing-of-revolving-credit-facility-to-support-acquisition-strategy-execution</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-announces-closing-of-revolving-credit-facility-to-support-acquisition-strategy-execution</guid>
      <pubDate>Thu, 05 Feb 2026 05:00:00 GMT</pubDate>
      <description>$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditionsOwned</description>
    </item>
    <item>
      <title>Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-inc-appoints-will-cook-to-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-inc-appoints-will-cook-to-board-of-directors</guid>
      <pubDate>Wed, 03 Dec 2025 05:00:00 GMT</pubDate>
      <description>NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Strata Critical Medical, Inc. (“Strata” or the “Company”), a leading</description>
    </item>
    <item>
      <title>Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-hosts-2025-investor-day-provides-2026-and-medium-term-financial-guidance</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-hosts-2025-investor-day-provides-2026-and-medium-term-financial-guidance</guid>
      <pubDate>Mon, 17 Nov 2025 05:00:00 GMT</pubDate>
      <description>Event highlights multiple ongoing industry growth catalysts and a range of factors that should enable Strata to grow faster than the overall marketTeam</description>
    </item>
    <item>
      <title>Strata Critical Medical Announces Third Quarter 2025 Results</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-announces-third-quarter-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-announces-third-quarter-2025-results</guid>
      <pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
      <description>Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to</description>
    </item>
    <item>
      <title>Strata Critical Medical Announces Date for Third Quarter Ending September 30, 2025 Earnings Release Conference Call</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-announces-date-for-third-quarter-ending-september-30-2025-earnings-release-conference-call</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-critical-medical-announces-date-for-third-quarter-ending-september-30-2025-earnings-release-conference-call</guid>
      <pubDate>Thu, 09 Oct 2025 04:00:00 GMT</pubDate>
      <description>NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the third</description>
    </item>
    <item>
      <title>Strata Announces 2025 Investor Day</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-announces-2025-investor-day</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-announces-2025-investor-day</guid>
      <pubDate>Tue, 30 Sep 2025 04:00:00 GMT</pubDate>
      <description>NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, &quot;Strata&quot; or the &quot;Company&quot;), formerly known as Blade Air Mobility,</description>
    </item>
    <item>
      <title>Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/strata-acquires-keystone-perfusion-creating-integrated-organ-recovery-platform-diversifying-into-other-medical-services</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/strata-acquires-keystone-perfusion-creating-integrated-organ-recovery-platform-diversifying-into-other-medical-services</guid>
      <pubDate>Tue, 16 Sep 2025 04:00:00 GMT</pubDate>
      <description>Keystone is expected to generate approximately $65 million of revenue and approximately $13 million of Adjusted EBITDA(1) in the full-year 2025, with revenue</description>
    </item>
    <item>
      <title>Blade Completes Sale of Passenger Business and Planned Name Change to Strata Critical Medical, Begins Trading Under Ticker Symbol SRTA</title>
      <link>https://6ix.com/company/strata-critical-medical-inc/news/blade-completes-sale-of-passenger-business-and-planned-name-change-to-strata-critical-medical-begins-trading-under-ticker-symbol-srta</link>
      <guid isPermaLink="true">https://6ix.com/company/strata-critical-medical-inc/news/blade-completes-sale-of-passenger-business-and-planned-name-change-to-strata-critical-medical-begins-trading-under-ticker-symbol-srta</guid>
      <pubDate>Fri, 29 Aug 2025 12:30:00 GMT</pubDate>
      <description>NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), today announced the successful closing of the previously announced divestiture of the Company&apos;s Passenger business to Joby Aviation, Inc. (NYSE: JOBY). Joby has elected to pay the up-front consideration in stock. The Company may receive up to an additional $35.0 million in consideration based on maintaining certain employe</description>
    </item>
  </channel>
</rss>